Skip to main content
. 2020 Sep 24;19:145. doi: 10.1186/s12933-020-01115-3

Table 6.

Univariate- and multivariate analyses for VAT SUVmax

Univariate Multivariate
Variable Coefficients (95% CI) p Coefficients (95% CI) p
Age (Continuous) 0.003 (− 0.004 to 0.011) 0.039* 0.002 (− 0.004 to 0.008) 0.486
Sex (Female vs male) 0.236 (0.074 to 0.399) 0.005* − 0.007(− 0.141 to 0.127) 0.92
BMI (Continuous) 0.02 (− 0.005 to 0.045) 0.113
WC (Continuous) 0.002 (− 0.004 to 0.009) 0.476
HTN (Negative vs Positive) 0.256 (0.091 to 0.421) 0.003* 0.036 (− 0.094 to 0.165) 0.586
DM (Negative vs Positive) 0.206 (0.03 to 0.382) 0.023* 0.075 (− 0.06 to 0.21) 0.088
Dyslipidemia (Negative vs Positive) 0.273 (0.112 to 0.434) 0.001* − 0.011 (− 0.14 to 0.119) 0.867
Current smokers (None vs Yes) 0.218 (0.045 to 0.392) 0.014* 0.132 (− 0.015 to 0.279) 0.077
hsCRP (Continuous) 0.006 (0.001 to 0.01) 0.013* 0 (− 0.003 to 0.004) 0.774
Spleen SUVmax (Continuous) 0.519 (0.404 to 0.634) < 0.001* 0.302 (0.16 to 0.443) < 0.001*
BM SUVmax (Continuous) 0.404 (0.329 to 0.478) < 0.001* 0.205 (0.086 to 0.325) 0.001*
VAT area (Continuous) 0.001 (0.000 to 0.002) 0.002* 0.001 (0 to 0.001) 0.12
SAT area (Continuous) 0 (− 0.001 to 0) 0.308

BMI body mass index, WC waist circumference, HTN hypertension, DM diabetes mellitus, hsCRP high-sensitivity C-reactive protein, SUVmax maximum standardized uptake value, BM bone marrow, VAT visceral adipose tissue, SAT subcutaneous adipose tissue, CI confidence interval

* Statistically significant difference